Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

8.1K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
8.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Cancer Therapies02:49

Cancer Therapies

10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Cancer Therapies02:49

Cancer Therapies

3.0K
3.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Basal-bolus or premixed? Shedding light on optimal insulin regime for type 1 diabetes.

Biomedical journal·2019
Same author

Dengue in Taiwan: Pointing the finger at Aedes aegypti.

Biomedical journal·2018
Same author

The influenza chronicles: From the 1918 pandemic to current understanding of host defense mechanisms.

Biomedical journal·2018
Same author

Tainted air: The link between pollution and Alzheimer's disease.

Biomedical journal·2018
Same author

Saliva biomarkers in neurological disorders: A "spitting image" of brain health?

Biomedical journal·2018
Same author

Microbes are off the menu: Defective macrophage phagocytosis in COPD.

Biomedical journal·2018
Same journal

Exploring the mechanism of acupuncture for Chronic Atrophic Gastritis based on bioinformatics and network topology strategies.

Biomedical journal·2026
Same journal

From Intradiscal Pressure to Multimodal Estimation of Lumbar Spinal Loads.

Biomedical journal·2026
Same journal

Coumarins as modulators of autophagy and PI3K/mTOR signaling: implications for next-generation cancer therapies.

Biomedical journal·2026
Same journal

Impact of Genetic Variants in Cyclophosphamide-Metabolizing Enzymes on Clinical Outcomes After Haploidentical Hematopoietic Stem Cell Transplantation.

Biomedical journal·2026
Same journal

PRMT5-mediated methylation of LKB1 controls PD-L1 expression in NSCLC.

Biomedical journal·2026
Same journal

Ultrasound-Guided Intervention in Adhesive Capsulitis: A Comprehensive Review of Therapeutic Strategies.

Biomedical journal·2026
See all related articles

Related Experiment Video

Updated: Apr 1, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.3K

Positive perspectives from proton therapy.

Emma Louise Walton1

  • 1Staff Writer at the Biomedical Journal, 56 Dronningens Gate, 7012 Trondheim, Norway.

Biomedical Journal
|October 14, 2015
PubMed
Summary
This summary is machine-generated.

Proton therapy offers cancer treatment benefits, while excessive doses of a fruit ripening agent proved toxic in an animal study. Research also explores the genetics of stroke and childhood leukemia.

More Related Videos

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

3.3K
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.7K

Related Experiment Videos

Last Updated: Apr 1, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.3K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

3.3K
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.7K

Area of Science:

  • Oncology
  • Toxicology
  • Genetics

Background:

  • Emerging benefits of proton therapy in cancer treatment.
  • An animal study investigating the toxicity of a common fruit ripening agent at excessive doses.
  • Exploration of the genetic factors contributing to stroke and childhood leukemia.

Discussion:

  • Proton therapy's potential to improve cancer treatment outcomes.
  • The toxicological profile of fruit ripening agents and implications for safety.
  • Understanding the genetic underpinnings of complex diseases like stroke and leukemia.

Key Insights:

  • Proton therapy presents a promising advancement in oncological care.
  • Excessive concentrations of the fruit ripening agent exhibit toxicity.
  • Genetic research provides insights into the etiology of stroke and childhood leukemia.

Outlook:

  • Further research into proton therapy's efficacy and applications.
  • Establishing safe dosage guidelines for fruit ripening agents.
  • Advancing genetic research for improved diagnostics and therapeutics for stroke and leukemia.